Outcomes of Factor Xa Inhibitor-based Regimens Versus Dual Antiplatelet Therapy in Managing Infrageniculate Critical Limb Ischemia Post Angioplasty
Background: Critical limb-threatening ischemia (CLTI) represents the most advanced stage of peripheral arterial disease and is associated with high rates of limb loss and mortality. Although dual antiplatelet therapy (DAPT) is commonly used following infrageniculate endovascular revascularization, its effectiveness in...